These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 22079532
1. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA). Shu JC, Chia JH, Siu LK, Kuo AJ, Huang SH, Su LH, Wu TL. Int J Antimicrob Agents; 2012 Mar; 39(3):217-22. PubMed ID: 22079532 [Abstract] [Full Text] [Related]
3. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S. Pathol Biol (Paris); 2009 Mar; 57(7-8):530-5. PubMed ID: 18977099 [Abstract] [Full Text] [Related]
4. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A. J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605 [Abstract] [Full Text] [Related]
5. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Lee JY, Ko KS. Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564 [Abstract] [Full Text] [Related]
9. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital. Liu Y, Li XY, Wan LG, Jiang WY, Li FQ, Yang JH. Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862 [Abstract] [Full Text] [Related]
10. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa. De Rosa A, Mutters NT, Mastroianni CM, Kaiser SJ, Günther F. Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264 [Abstract] [Full Text] [Related]
11. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Ocampo-Sosa AA, Cabot G, Rodríguez C, Roman E, Tubau F, Macia MD, Moya B, Zamorano L, Suárez C, Peña C, Domínguez MA, Moncalián G, Oliver A, Martínez-Martínez L, Spanish Network for Research in Infectious Diseases (REIPI). Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967 [Abstract] [Full Text] [Related]
12. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S. J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142 [Abstract] [Full Text] [Related]
13. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762 [Abstract] [Full Text] [Related]
14. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene. Wołkowicz T, Patzer JA, Kamińska W, Gierczyński R, Dzierżanowska D. J Glob Antimicrob Resist; 2016 Dec; 7():119-125. PubMed ID: 27750158 [Abstract] [Full Text] [Related]
15. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ. Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276 [Abstract] [Full Text] [Related]
16. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C, Sáenz Y. Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145 [Abstract] [Full Text] [Related]
19. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN. J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963 [Abstract] [Full Text] [Related]
20. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment. Shen JL, Fang YP. Genet Mol Res; 2015 Jun 18; 14(2):6723-32. PubMed ID: 26125881 [Abstract] [Full Text] [Related] Page: [Next] [New Search]